SC should instead investigate local IBs which give high unachievable TP with conflict interest by issuing CWs.

MBB, CIMB & RHB has used ESG as an excuse to revise downwards the TP. Assess the target price by using normal P/E ratio in this extraordinary time is inappropriate. Another few good examples are Genting, GenM & Airport. They have ridiculously high PE but they all are good buy now to reap the good returns in another 2 - 3 years.

Yes, good yield for next few years. But do expect a big capital loss after that!

Food index prices rose in October for fifth straight month. Prices of American grain is surging, & so CPO due to:

1. Dry weather from La Nina is interfering with planting of in Brazil
2.China ban on imports of Australian crops, e.g. barley, wheat
3. Russia government is mulling a quota ban on wheat exports

My prediction is more prudent, gross profit around 11m. Good enough for me.

Will hold through Q4 QR for the extraordinary profit.

LLB termination will happen only after 18 months the earliest if it materialized. How many long term investors here?

IOI mentioned in its QR result that CPO price will maintain above 3000 till Feb 21.

In addtional, FGV has no labor shortage issue. The estates are owned by settlers.

All IBs are not given enough attention to plantation stocks. Market is more efficient & reacts better to current CPO price than all these ‘analysts’.

Soon they will change their tune following market movements.

Finished building my plantation portfolio. Last batch bought at 1.10 today. Fantastic Q3 & Q4 results are guaranteed looking at Nov & Dec future price.

That’s also the reason why Top Glove boss wanna support at current share price through share buy back, in order for him to dispose his stake in the company through listing in HK, just like how he disposed 5% of his shareholding via secondary listing in Sinagapore back in 2016.

The share price dropped right after the secondary listing in Singapore.

He got the right valuation model for glove counters at this super growth period. Just two points to add:
1) this high profit period will last at least 2 years, as backed by the order in hands till 620 days
2) the price to assets is overstated, as 50% profit will be given back to shareholders as per dividend policy.

So nett nett it’s come back to the total valuation given by Sifu, ie around 30+b

Boss mentioned no bonus issue plan for the time being, looking at the poor share price performance of its peers post bonus issued date.

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

Just to give everyone head-up, Oxford vaccine 3rd phase trial result will be out by this month end. Vaccine will ready for emergency use by Sep this year, as per Citi research report.

(Big) funds are out from the glove counters, that’s the reason why no rotate play fr one glove counter to another glove counter. Other reasons are just noises.

Apple, better mind your own business if you have no idea what’s trigger the recent sell down of all glove stocks. Better promote more at TopGlove forum to push up the price. Majority has moved to private chat group.

Phillip sold all his top glove shares at RM14 & make millions profit. The funds reinvested in o&g sector.

Top Glov share price will drop below RM14 again? I can’t imagine.

Citi group give higher TP price for Kossan 31.20 vs Supermx 24.90.
More will come.

Fantastic quarter result doesn’t guaranteed good future share price, cos it was past & fully reflected. A good example is Supermx.

Agree with Warchest.
Profit taking by big players started even before Supermx QR result was out due to vaccine development.

Anyway, the corona cases are real, demand shortage of gloves & ASP price increase is real (new plant takes mora than 1 year to start operating), the vaccine immunity can’t last longer than 1 year is real (wonder how Russian prove the vaccine immunity can last 2 years, whereas the pandemic started only end of last year).

Why sell cheap at current price?

UG Healthcare today announced >1000% increase in half yearly net profit from S$1.2m to S$12.6m.

Lukey_Greek Apple, you think my estimation of Supermax gross profit of RM500m just plucked from the sky? What i want to tell you is that the price of supermax has fully relected the ASP as shared in the analyst briefing slide.

To get 1b net profit for next quarter, even take in add. 2.2b production from Block B of Plant no. 12, ASP still need to increase further from USD180.

If you dont believe the slides, Supermax market price has spoken itself today.

Apple, you got the hints? Let me make it clear, the Jul ASP only up 13% compared to last quarter for Supermx. In comparison, Harta increase 30% each for Jul & Aug, whereas Kossan will up 20% & 40% respectively for next 2 months.

Which counters have higher potential? & which one is fairly price now? Smart investor like you should have a better answer.

The outcome of the review of MSCI Malaysia Index will be known on 12th Aug. Hope Kossan will be upgraded from Small Cap to Large & Mid cap segment, same category with Harta & TopGlov.

Fast & furious.

Last chance for IBs to collect tickets before excellence QR result from both Supermx & UG Healthcare.


Good signs instead.

This is a very interesting week. The best of 2 OBM counters will be releasing their result:
a) 10/8 (Mon) - Supermx
b) 11/8 (Tue) - UG Healthcare

Supermx has moved forward their result announcement earlier fr 11/8 to 10/8 to avoid UG Healthcare to steal its limelight. From here we know which counter will have better performance.

Anyway, both counters will have outstanding result. Hopefully, the stock price running will follow for both 1st & 2nd tier glove stocks. Enjoy the show!

In CIMB report dated yesterday, Harta will increase 30% ASP in 3Q20, and another 30% in 4Q20. TP for Harta increased to 24.30.

Just wait for the same announcement from Kossan. No sweats to hold laggard players, cause ASP also laggard.

No impact, instead you can read it as good news.

This has nothing to do with Hextar Global. The Executive Director buy this under his own company & personal capacity.

1. Why stock price for big 4 dropped early this morning before Harta released its result?
2. Why Harta rebounded strongly after a weak result?

Its because market already knew & moved in advanced. Fund managers have been waiting for this opportunity to grab cheap tickets of Harta, in big volume.

Let the share price speak itself. Just look at the share price by this month end & year end.

The sell off is temporary, tickets are not many. Pandemic is here to stay for at least another 2 years. Demand for glove after pandemic will increase 30-40%. But glove price can’t increase another 2 or 3 folds for OBM. Manufacturing price for OEM is catching up soon & fast.

The choice is yours if you still wanna chase high on Supermx.

No one is promoting Harta here except you in your earlier posts. Mr_Kiah the first one highlighted Harta result is not good (I know also). Dont act like you know stock investment skills.

The most you know maybe the quarter profit through your previous network.

According to Hartalega CEO Kuan Mun Leong, there will be structural step-up increase in demand of 30%-40% post-pandemic period. Demand in the next few years will still be very very strong.

https://www.youtube.com/watch?v=vDhgdI4aPXI

Computation on the adjustment of CW exercise price for bonus issues

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=105154&name=EA_GA_ATTACHMENTS

Maybank top pick is Kossan while CIMB top pick is TopGlov. I will wait for the price of Kossan catching up with Supermx in the coming weeks, while someone keeps giving same stale news. How could you make same investment decision based on info available 2 months ago?

Bonus issue is definitely on the card for Kossan by this year, most likely in Aug together with Q2 result, in order to list the bonus shares and boost the market cap by this year end. It’s crucial to beat supermx market cap to guarantee to be placed as a FBM KLCI component stock by this year.

Maybank TP 19.50 & UOB 19.40. CIMB revised TP 16.40 was history.

Cos market will be in red dragged by profit taking activities triggered by Supermax. That’s why we need to differentiate kossan with Supermax. Good apple vs bad apple...

Kossan Q3 ASP will increase 20% in Jul & another 20% in Aug. Total 40%. Supermax anyway near? ;-)

Second half will be OEM counters play. To match this 40%, OBM like Supermx need to sell 140% x USD 160 = USD 224, just to match back the profit increase in %. How likely this will happen? We are hoping for it too. Haha.

Kossan trading volume low cos much of the tickets are hold by the owner & fund managers. A small % is only hold by retail investors.

Absolute volume of the trading amount comparison among peers doesnt have much meanings on the share price, except on liquidity concern for big players. The more important is the relative of the trading volume for the same stock over different time period.

Supermx coming quarter gross profit hits 500m & Topglov hits 1b is a known fact. Seasoned glove investors who follows this forum should have known it.

To be a successful investor, you need to have 2nd level of thinking. An open secret everyone knows will not reward you much. You need to start position yourself for Jul to Sep result by now. If CY 3Q ASP same like 2Q, there will no profit grow for Supermx. Why? It already sell at maximum price now! Its current price has already full reflected the coming quarter profit x 4 quarters, based on its 5 years average PE of 15.

You think uncle Koon switch stock to TopGlov without waiting supermx result out is for fun? Why not he make 2 rounds by selling Supermx after the quarter result is out then only buy TopGlov?

Hold on tight your Kossan shares. Not much tickets in the market. Rotate play is started among big 4.

Supermx share price will be stampede once the result is out. The QR result is the last carrot tangled that keep its investors around. This is the last chance to exit before it’s happened. Good luck to supermx holders!

Glove is gold, & not the business model. Who has more gloves, who is the king.

To switch from OEM to OBM during this period is so easy like a piece of cake. Buyers are queuing long in front of your factory & you dont even need to do any marketing, especially you're the big 3. Then why big 3 dont do? Answer has been given by Kossan boss which make laugh by ppl who dont understand business... sustainability after post-Covid.

Uncle Koon sell call on Supermx.

Spot price of glove peaked at USD160 since mid April and stagnant till now. Supermax has enjoyed this price for most of its Q2 revenue due to its unique OBM model. its Q2 profit will be fantastic, as reflected in its current share price & today's bonus issued. To up another 100% profit in Q3, it needs to sell its glove at USD320. Is it possible?

The key drivers of profit is ASP, where supermx has already reaped the max in its Q2 result. In contrast, there are still plenty of potential upside in ASP for OEM players like TopGlov & Kossan. They has so far increased 5% in ASP (<USD30) (to be reflected in Kossan Q2 result). Based on Supermx analyst slides, its manufacturing price has increased to USD90, which indicates potential profit of 1000% to both TopGlov & Kossan, perhaps happened by this year end.

There will be shift in the supply chain which will create temporary shortage in US, & drive the price up further. US consumes 30% of global supply per year.

I wont blame the owner of Kossan, at least he didnt blow up the Kossan share price during the AGM, or interviewed by Bloomberg. He just cashed out small portion of share for his other purposes in life, when the price was high & the volume was huge, with the aim to keep minimal disruption to Kossan share price.

He might still sell more when the price goes higher in future... The choice is your if you believe in his management style, & not whether he sell his small portion of share, when its right time to realise some profit.

**It will be bad signal if he keep pressing the share price down due to his selling. 14th Jul selling is coincide with some 'big' event which not triggered by him. Let keep monitor.

Even Top Glove might be appear as a pure winner from this tragedy. If i was the boss, i will sell the gloves to other countries, perhaps emerging market, eg India, & Latin America, with SPOT price.

According to MARGMA, glove makers having an average order backlog of 6-8 months, as well as the growing severity of Covid-19 globally. For example, India has seen its glove consumption rise from 4 to 30 pcs per capita, given its large population of 1.2bn, and the demand for gloves is outstripping supply in the region.

Which counters will be benefited the most if Top Glove couldn't access to US market? Market will only reward ppl with independent thinking & not the herd mentality.

Mystery of the sudden dropped yesterday has been revealed, as per uncle Koon's recent posts on tulips & OTB's advice to his followers to sell supermx.

Hold tight to your Kossan shares. Supermax share price has fully reflected after up 10 folds & Harta QR result will be up much lesser in % than Kossan. Expect to see continous stagnant or drop in Harta. Hope it wont pull the legs of others.

Time to focus on big 2 now. Let the high risk taker investors to chase the small cap glove stocks for higher returns.

Seems like uncle Koon lost his confident. Either way he is right by giving ambiguous signal. The price ended today will tell the direction. With this kind of trading volume, he is just another individual investor vs local & foreign fund.